Overview
Location
Ireland, Laois, Huntington
Employees
51-200
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 5, 2024 | New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal Cancers | Researchers found that omitting the bolus-specific 5-flourouracil (5-FU) portion from common chemotherapy regimens could improve tolerability for patients without sacrificing treatment effectiveness. PLYMOUTH MEETING, Pa., Sept. 5, 2024 /PR... |
| May 16, 2024 | Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN--Journal of the National Comprehensive Cancer Network | Chief of the Genitourinary Division for Fox Chase Cancer Center, and Member of two NCCN Guidelines Panels to oversee high-impact oncology research journal. PLYMOUTH MEETING, Pa., May 16, 2024 /PRNewswire/ -- Daniel M. Geynisman, MD, is bein... |
| Mar 25, 2024 | Health | Breast cancer test may make bad chemotherapy recommendations for Black patients, UIC study shows | While the rest of the world was in the throes of the pandemic, Valletta Howard was wrapping her mind around a breast cancer diagnosis. After finding a lump in her left breast in April 2021, she confirmed it with a mammogram and ultrasound i... |
| Jul 31, 2023 | Registration Is Open for the 11th JADPRO Live, an Educational Conference for Oncology Advanced Practitioners | "We’re thrilled to welcome back our passionate community of oncology APs,” said conference chair Amy Pierre, MSN, RN, ANP-BC, of Memorial Sloan Kettering Cancer Center/Flatiron Health. “There is no question that advanced practitioners ... |
| Mar 27, 2023 | How one woman’s rare type of ovarian cancer was almost overlooked | (BPT) - Richmond, Virginia, resident Tiffany Stout never realized that in the prime of her life she would not only be battling cancer, but also a cancer that is rare with limited treatment options. She quickly learned how to become an advoc... |
| Dec 30, 2022 | Independence Valued Over Survival for Neuroendocrine Tumor Patients | FRIDAY, Dec. 30, 2022 (HealthDay News) -- Independence is valued over survival among adult patients with neuroendocrine tumors (NETs), according to a study published in the December issue of the Journal of the National Comprehensive Cancer ... |
| Dec 22, 2022 | Re-engineering Cancer Clinical Trials at Scale | In his book, Applied Minds: How Engineers Think, Guru Madhavan explores the mental makeup of engineers. His framework is built around a flexible intellectual toolkit called modular systems thinking. He says that “systems-level thinking is m... |
| Nov 10, 2022 | Health Care Access May Affect Receipt of Therapy in Ovarian Cancer | THURSDAY, Nov. 10, 2022 (HealthDay News) -- Health care access (HCA) dimensions are associated with receipt of guideline-concordant therapy, but they do not fully explain racial disparities among patients with ovarian cancer, according to a... |
| Aug 2, 2022 | Many Online Pharmacies Sell Imatinib Without Prescription | TUESDAY, Aug. 2, 2022 (HealthDay News) -- Many online pharmacies sell imatinib without requiring a prescription, and nearly one-quarter do not include warnings related to imatinib, according to a study published in the July issue of the Jou... |
Show more
Reviews 0
FAQ about JNCCN.org
What has the press written about JNCCN.org?
Parsers VC has collected 16 articles mentioning JNCCN.org, among them “New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal Cancers” (Sep 5, 2024) and “Dr. Daniel Geynisman Named New Editor-in-Chief for JNCCN--Journal of the National Comprehensive Cancer Network” (May 16, 2024).
Is JNCCN.org still active?
Yes, JNCCN.org is active; its latest activity on Parsers VC dates from Apr 2, 2025.